PDL BioPharma, Inc. (PDLI) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q1 EPS of $0.44, $0.01 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $139.7 million versus the consensus estimate of $130.93 million.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Yum! Brands (YUM) PT Lowered to $180 at Argus
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
